| Turner SR, Pinsk M Ondansetron-associated Hypokalemia in a 2-year-old With Pre-B-cell ALL. [Journal Article] J Pediatr Hematol Oncol 2008 Jan; 30(1):58-60. Abstract | Full Citation | Find Related Articles |
| Apostolidou E, Swords R, Alvarado Y, et al. Treatment of acute lymphoblastic leukaemia : a new era. [Journal Article] Drugs 2007; 67(15):2153-71. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Parnes A, Bifulco C, Vanasse GJ A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases. [Journal Article] Br J Haematol 2007 Oct; 139(1):164-5. Full Citation | Find Related Articles |
| Dinndorf PA, Gootenberg J, Cohen MH, et al. FDA Drug Approval Summary: Pegaspargase (Oncaspar(R)) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL). [JOURNAL ARTICLE] Oncologist 2007; 12(8):991-998. Abstract | Full Citation | Find Related Articles |
| Fu CH, Sakamoto KM PEG-asparaginase. [Journal Article] Expert Opin Pharmacother 2007 Aug; 8(12):1977-84. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Avramis VI, Martin-Aragon S, Avramis EV, et al. Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models. [Journal Article] Anticancer Res 2007 Jul-Aug; 27(4C):2561-72. Abstract | Full Citation | Find Related Articles |
| Salzer WL, Devidas M, Shuster JJ, et al. Intensified PEG-L-asparaginase and Antimetabolite-based Therapy for Treatment of Higher Risk Precursor-B Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. [JOURNAL ARTICLE] J Pediatr Hematol Oncol 2007 Jun; 29(6):369-375. Abstract | Full Citation | Find Related Articles |
| Armstrong JK, Hempel G, Koling S, et al. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. [JOURNAL ARTICLE] Cancer 2007 May 21; 110(1):103-111. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Avramis VI, Spence SA Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients. [JOURNAL ARTICLE] J Pediatr Hematol Oncol 2007 Apr; 29(4):239-247. Abstract | Full Citation |
| Dietel V, Bührdel P, Hirsch W, et al. Cerebral sinus occlusion in a boy presenting with asparaginase-induced hypertriglyceridemia. [Journal Article] Klin Padiatr 2007 Mar-Apr; 219(2):95-6. Abstract | Full Citation | Find Related Articles |
 |